Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xeroderris stuhlmannii extract is a botanical plant extract derived from *Xeroderris stuhlmannii*, a medicinal plant used traditionally in Zimbabwe for type 2 diabetes mellitus and related complications. The available published evidence is preclinical and centers on phytochemical constituents with **inhibitory activity against digestive α-glucosidase enzymes**, supported by in vitro testing and in silico docking, suggesting a potential antihyperglycemic mechanism through delayed carbohydrate digestion and glucose absorption. It is not an approved pharmaceutical product, and no specific commercial developer, manufacturer, standardized formulation, or clinical development program is established from the provided evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xeroderris stuhlmannii extract.